Antimicrobial Agents and Chemotherapy

Title Publication Date Language Citations
Evernimicin (SCH27899) Inhibits both Translation and 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells2000/06/01English
Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates2002/03/01English
Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240→Gly2001/08/01English
Antimalarial Activities of Peptide Antibiotics Isolated from Fungi2001/01/01English
Thalidomide Inhibits Granulocyte Responses in Healthy Humans after Ex Vivo Stimulation with Bacterial Antigens2001/05/01English
In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV2002/06/01English
Evaluation of T-3811ME (BMS-284756), a New Des-F(6)-Quinolone, for Treatment of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniae in Rabbits2002/06/01English
What Constitutes an Extended-Spectrum β-lactamase?2002/02/01English
In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group Strains2001/08/01English
Integration of Integrons in res Sites2002/06/01English
Macrolide-Resistant Streptococcus pneumoniae in Canada during 1998–1999: Prevalence of mef (A) and erm (B) and Susceptibilities to Ketolides2001/07/01English
Activities of Gemifloxacin and Five Other Antimicrobial Agents against Listeria monocytogenes and Coryneform Bacteria Isolated from Clinical Samples2001/08/01English
Overproduction and Biochemical Characterization of the Chryseobacterium meningosepticum BlaB Metallo-β-Lactamase2002/06/01English
In Vitro Activity of the New Ketolide Telithromycin Compared with Those of Macrolides against Streptococcus pyogenes : Influences of Resistance Mechanisms and Methodological Factors2000/11/01English
Morphological Changes and Lysis Induced by β-Lactams Associated with the Characteristic Profiles of Affinities of Penicillin-Binding Proteins in Actinobacillus pleuropneumoniae2000/06/01English
Peptide Deformylase as an Antibacterial Drug Target: Assays for Detection of Its Inhibition in Escherichia coli Cell Homogenates and Intact Cells2001/04/01English
Broad-Spectrum Antiherpes Activities of 4-Hydroxyquinoline Carboxamides, a Novel Class of Herpesvirus Polymerase Inhibitors2002/03/01English
Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects2024/04/22English
Genomic characterization of ST38 NDM-5-producing Escherichia coli isolates from an outbreak in the Czech Republic2024/04/16English
Precise genome editing underlines the distinct contributions of mutations in ERG11 , ERG3 , MRR1 , and TAC1 genes to antifungal resistance in Candida parapsilosis2024/04/16English
A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance2024/04/03English
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model2024/04/03English
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa2024/04/03English
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness2024/04/03English
Interspecies variability in protein binding of antibiotics basis for translational PK/PD studies—a case study using cefazolin2024/04/03English
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis2024/04/03English
A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia2024/04/03English
Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model2023/10/18English
Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo2023/10/18English
Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling2023/10/18English